Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.
Sprigg N, Flaherty K, Appleton JP, Al-Shahi Salman R, Bereczki D, Beridze M, Christensen H, Ciccone A, Collins R, Czlonkowska A, Dineen RA, Duley L, Egea-Guerrero JJ, England TJ, Krishnan K, Laska AC, Law ZK, Ozturk S, Pocock SJ, Roberts I, Robinson TG, Roffe C, Seiffge D, Scutt P, Thanabalan J, Werring D, Whynes D, Bath PM; TICH-2 Investigators. Sprigg N, et al. Among authors: christensen h. Lancet. 2018 May 26;391(10135):2107-2115. doi: 10.1016/S0140-6736(18)31033-X. Epub 2018 May 16. Lancet. 2018. PMID: 29778325 Free PMC article. Clinical Trial.
The relationship between baseline blood pressure and computed tomography findings in acute stroke: data from the tinzaparin in acute ischaemic stroke trial (TAIST).
Sare GM, Bath PM, Gray LJ, Moulin T, Woimant F, England T, Geeganage C, Christensen H, De Deyn PP, Leys D, O'Neill D, Ringelstein EB; TAIST Investigators. Sare GM, et al. Among authors: christensen h. Stroke. 2009 Jan;40(1):41-6. doi: 10.1161/STROKEAHA.108.526665. Epub 2008 Nov 6. Stroke. 2009. PMID: 18988907 Clinical Trial.
Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial.
England TJ, Bath PM, Sare GM, Geeganage C, Moulin T, O'Neill D, Woimant F, Christensen H, De Deyn P, Leys D, Ringelstein EB; TAIST Investigators. England TJ, et al. Among authors: christensen h. Stroke. 2010 Dec;41(12):2834-9. doi: 10.1161/STROKEAHA.109.573063. Epub 2010 Oct 28. Stroke. 2010. PMID: 21030711 Clinical Trial.
Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST).
Geeganage C, Tracy M, England T, Sare G, Moulin T, Woimant F, Christensen H, De Deyn PP, Leys D, O'Neill D, Ringelstein EB, Bath PM; for TAIST Investigators. Geeganage C, et al. Among authors: christensen h. Stroke. 2011 Feb;42(2):491-3. doi: 10.1161/STROKEAHA.110.596163. Epub 2010 Dec 23. Stroke. 2011. PMID: 21183747 Clinical Trial.
Quality of life after ischemic stroke varies in western countries: data from the tinzaparin in Acute Ischaemic Stroke Trial (TAIST).
Sprigg N, Gray LJ, Bath PM, Christensen H, De Deyn PP, Leys D, O'Neill D, Ringelstein EB; TAIST Investigators. Sprigg N, et al. Among authors: christensen h. J Stroke Cerebrovasc Dis. 2012 Oct;21(7):587-93. doi: 10.1016/j.jstrokecerebrovasdis.2011.01.007. Epub 2011 Mar 9. J Stroke Cerebrovasc Dis. 2012. PMID: 21388828 Clinical Trial.
European research priorities for intracerebral haemorrhage.
Steiner T, Petersson J, Al-Shahi Salman R, Christensen H, Cordonnier C, Csiba L, Harnof S, Krieger D, Mendelow D, Molina C, Montaner J, Overgaard K, Roine RO, Schmutzhard E, Tatlisumak T, Toni D, Stapf C; European Research Network on Intracerebral Haemorrhage. Steiner T, et al. Among authors: christensen h. Cerebrovasc Dis. 2011;32(5):409-19. doi: 10.1159/000330653. Epub 2011 Oct 8. Cerebrovasc Dis. 2011. PMID: 21986448 Free PMC article. Review.
Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388).
TARDIS Trial Investigators; Krishnan K, Beridze M, Christensen H, Dineen R, Duley L, Heptinstall S, James M, Markus HS, Pocock S, Ranta A, Robinson T, Nikola N, Venables G, Bath P. TARDIS Trial Investigators, et al. Among authors: christensen h. Int J Stroke. 2015 Oct;10(7):1159-65. doi: 10.1111/ijs.12538. Epub 2015 Jun 16. Int J Stroke. 2015. PMID: 26079743 Free PMC article. Clinical Trial.
3,132 results